Advertisement

Current Infectious Disease Reports

, Volume 15, Issue 4, pp 299–306 | Cite as

Expatriates: Special Considerations in Pretravel Preparation

  • Cassandra M. Pierre
  • Poh-Lian Lim
  • Davidson H. Hamer
Invited Commentary

Abstract

Expatriates comprise a diverse set of travelers who face unique medical, psychiatric, and non-health-related risks as a result of increased exposure to host country environment and associated lifestyle. Expatriates have an increased risk of developing malaria, gastrointestinal disorders, latent tuberculosis, vaccine-preventable infections, and psychological disorders, when compared with other travelers, yet the majority of existing pretravel guidelines have been designed to suit the needs of nonexpatriates. Although greater interest in expatriate health issues has led to improved characterization of illness in this population, expatriate-specific risk mitigation strategies—including modifications to chemoprophylaxis recommendations, limiting tuberculosis exposure, and prevention of occupational or sexual blood-borne virus transmission—are poorly described. Occupations and destinations affect travel-related disease risk and should inform the pretravel consultation.

Keywords

Expatriates Rabies vaccine Japanese encephalitis vaccine Chemoprophylaxis Malaria International travel 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

Cassandra M. Pierre, Poh-Lian Lim, and Davidson H. Hamer declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    UNWTO. UNWTO World Tourism Barometer, interim update, September 2012. Available from http://dtxtq4w60xqpw.cloudfront.net/sites/all/files/pdf/unwto_barom12_05_sept_excerpt.pdf
  2. 2.
    • Patel D, Easmon C, Seed P, et al. Morbidity in expatriates—a prospective cohort study. Occup Med. 2006;56:345–52. This prospective cohort study evaluated the incidence of infectious and noninfectious illness among 2020 British corporate expatriates over a 1-year period.CrossRefGoogle Scholar
  3. 3.
    •• Lim P, Han P, Chen LH, et al. Expatriates ill after travel: results from the Geosentinel Surveillance Network. BMC Infect Dis. 2012;12:386. This retrospective (GeoSentinel network) study evaluated the proportionate morbidity and odds ratio of travel-related diseases among 2,883 returned expatriates and 11,910 nonexpatriate travelers. It is one of the few studies to stratify disease risk outcomes on expatriate occupation.CrossRefPubMedGoogle Scholar
  4. 4.
    Dijkstra J, Chappuis F, Loutan L. Vaccine-preventable diseases in long-term expatriates. J Travel Med. 2005;12:S47–57.CrossRefPubMedGoogle Scholar
  5. 5.
    LaRocque RC, Rao S, Lee J, Ansdell V, et al. Global TravEpiNet: A national consortium of clinics providing care to international travelers—analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009–2011. Clin Infect Dis. 2012;54:455–62.CrossRefPubMedGoogle Scholar
  6. 6.
    Hamer D, Ruffing R, Callahan M, et al. Knowledge and use of measures to reduce health risks by corporate expatriate employees in western Ghana. J Travel Med. 2008;15:237–42.CrossRefPubMedGoogle Scholar
  7. 7.
    Jones S. Medical aspects of expatriate health: health threats. Occup Med (Lond). 2000;50:572–8.CrossRefGoogle Scholar
  8. 8.
    Patel D, Easmon CJ, Dow C, et al. Medical repatriation of British diplomats resident overseas. J Travel Med. 2000;7:64–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Rossi I, Genton B. The reliability of pre-travel history to decide on appropriate counseling and vaccinations: a prospective study. J Travel Med. 2012;19:284–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Hamer DH, Connor BA. Travel health, knowledge, attitudes and practices among United States travelers. J Travel Med. 2004;11:23–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Heywood AE, Watkins RE, Iamsirithaworn S, et al. A cross-sectional study of pre-travel health-seeking practices among travelers departing Sydney and Bangkok airports. BMC Publ Health. 2012;12:321.CrossRefGoogle Scholar
  12. 12.
    Gautret P, Parola P. Rabies pretravel vaccination. Curr Opinion Infect Dis. 2012;25:500–6.CrossRefGoogle Scholar
  13. 13.
    Gautret P, Parola P. Rabies vaccination for international travelers. Vaccine. 2012;30:126–33.CrossRefPubMedGoogle Scholar
  14. 14.
    Piyaphanee W, Kittitrakul C, Lawpoolsri S, et al. Risk of potentially rabid animal exposure among foreign travelers in Southeast Asia. PLoS Negl Trop Dis. 2012;6:e1852.CrossRefPubMedGoogle Scholar
  15. 15.
    Mills D, Lau CL, Fearnley EJ, Weinstein P. The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule—a case series of 420 Travelers. J Travel Med. 2011;18:327–32.CrossRefPubMedGoogle Scholar
  16. 16.
    Mayer CA, Neilson AA. Japanese encephalitis: Prevention in travelers. Aust Fam Physician. 2010;39:389–94.PubMedGoogle Scholar
  17. 17.
    Burchard GD, Caumes E, Connor BA, et al. Expert opinion on vaccination of travelers against Japanese Encephalitis. J Travel Med. 2009;16:204–16.CrossRefPubMedGoogle Scholar
  18. 18.
    Fischer M, Lindsey N, Staples JE, Hills S. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59(RR-1):1–27.Google Scholar
  19. 19.
    Askling HH, Rombo L, Andersson Y, et al. Hepatitis A risk in travelers. J Travel Med. 2009;16(4):233–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Nielsen US, Thomsen RW, Cowan S, et al. Predictors of travel-related hepatitis A and B among native adult Danes: A nationwide case–control study. J Infect. 2012;64:399–408.CrossRefPubMedGoogle Scholar
  21. 21.
    Hillel O, Potasman I. Correlation between adherence to precautions issued by the WHO and diarrhea among long-term travelers to India. J Travel Med. 2005;12:243–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Soonawala D, Vlot J, Visser L. Inconvenience due to travelers’ diarrhea: a prospective follow-up study. BMC Infect Dis. 2011;11:322.tg.CrossRefGoogle Scholar
  23. 23.
    Hachiya M, Kikuchi H, Mizoue T. Descriptive epidemiology of travel-associated diarrhea based on surveillance data at Narita International Airport. J Travel Med. 2010;17:105–10.CrossRefPubMedGoogle Scholar
  24. 24.
    Piyaphanee W, Kusolsuk T, Kittitrakul C, et al. Incidence and impact of travelers’ diarrhea among foreign backpackers in Southeast Asia: A result from Khao San Road, Bangkok. J Travel Med. 2011;18:109–14.CrossRefPubMedGoogle Scholar
  25. 25.
    Shlim DR, Hoge CW, Rajah R, et al. Echeverria P. Persistent high risk of diarrhea among foreigners in Nepal during the first 2 years of residence. Clin Infect Dis. 1999;29:613–6.CrossRefPubMedGoogle Scholar
  26. 26.
    De Santi VP, Nicand E, Lagathu G, et al. Incidence, etiology, and determinants associated with acute diarrhea among French forces deployed to Chad. J Travel Med. 2011;18:115–20.CrossRefGoogle Scholar
  27. 27.
    Kasper MR, Lescano AG, Lucas C, et al. Diarrhea outbreak during U.S. military training in El Salvador. PLoS One. 2012;7:e40404.CrossRefPubMedGoogle Scholar
  28. 28.
    Hu Y, Ren J, Zhan M, et al. Efficacy of rifaximin in prevention of travelers’ diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials. J Travel Med. 2012;19:352–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Alajbegovic S, Sanders JW, Atherly DE, Riddle MS. Effectiveness of rifaximin and fluoroquinolones in preventing travelers’ diarrhea (TD): a systematic review and meta-analysis. Systematic Reviews. 2012;1:39.CrossRefPubMedGoogle Scholar
  30. 30.
    •• Toovey S, Moerman F, van Gompel A. Special infectious disease risks of expatriates and long-term travelers in tropical countries. Part I: Malaria. J Travel Med. 2007;14:42–9. This review provides a rare and comprehensive assessment of malaria chemoprophylaxis and chemoprophylaxis alternatives in expatriates and long-term travelers.PubMedGoogle Scholar
  31. 31.
    Neuberger A, Klement E, Reyes CM, Stamler A. A cohort study of risk factors for malaria among healthcare workers in Equatorial Guinea: stay away from the ground floor. J Travel Med. 2010;17:339–45.CrossRefPubMedGoogle Scholar
  32. 32.
    Roukens A, Berg J, Barbey A, Visser L. Performance of self-diagnosis and standby treatment of malaria in international oilfield service employees in the field. Malaria J. 2008;7:128.CrossRefGoogle Scholar
  33. 33.
    Gutman J, Guarner J. Pediatric malaria: 8-year case series in Atlanta, Georgia, and review of the literature. J Travel Med. 2010;17:334–8.CrossRefPubMedGoogle Scholar
  34. 34.
    Massad E, Behrens BC, Coutinho FA, Behrens RH. Cost risk benefit analysis to support chemoprophylaxis policy for travelers to malaria endemic countries. Malaria J. 2011;10:130.CrossRefGoogle Scholar
  35. 35.
    Cairns M, Roca-Feltrer A, Garske T, et al. Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nature Comm. 2012;3:881.CrossRefGoogle Scholar
  36. 36.
    Meremikwu MM, Donegan S, Sinclair D, et al. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database Syst Rev. 2012;2, CD003756.PubMedGoogle Scholar
  37. 37.
    Byrne N. Urban malaria risk in sub-Saharan Africa: Where is the evidence? Travel Med Infect Dis. 2007;5:135–7.CrossRefPubMedGoogle Scholar
  38. 38.
    Schlagenhauf P, Petersen E. Standby emergency treatment of malaria in travelers: experience to date and new developments. Expert Rev Anti Infect Ther. 2012;10:537–46.CrossRefPubMedGoogle Scholar
  39. 39.
    Jorgensen P, Chanthap L, Rebueno A, et al. Malaria rapid diagnostic tests in tropical climates: the need for a cool chain. AmJTrop Med Hyg. 2006;74(5):750–4.Google Scholar
  40. 40.
    Korhonen C, Peterson K, Bruder C, Jung P. Self-Reported adverse events associated with antimalarial chemoprophylaxis in Peace Corps Volunteers. Am J Prev Med. 2007;33(3):194–9.CrossRefPubMedGoogle Scholar
  41. 41.
    Schlagenhauf P, Tschopp A, Johnson R, et al. Tolerability of malaria chemoprophylaxis in non-immune travelers to sub-Saharan Africa: multicenter, randomized, double blind, four arm study. BMJ. 2003;327:1078.CrossRefPubMedGoogle Scholar
  42. 42.
    Newton PN, Green MD, Mildenhall DC, et al. Poor quality vital anti-malarials in Africa—an urgent neglected public health policy. Malaria J. 2011;10:352.CrossRefGoogle Scholar
  43. 43.
    Burkholder JD, Joines R, Cunningham-Hill M, Xu B. Health and well-being factors associated with international business travel. J Travel Med. 2010;17:329–33.CrossRefPubMedGoogle Scholar
  44. 44.
    Brown RJ. Dominant stressors on expatriate couples during international assignments. Int J Hum Resour Manag. 2008;19:1018–34.CrossRefGoogle Scholar
  45. 45.
    Connorton E, Perry MJ, Hemenway D, Miller M. Humanitarian relief workers and trauma-related mental illness. Epidemiol Rev. 2012;34:145–55.CrossRefPubMedGoogle Scholar
  46. 46.
    Stevens G, Byrne S, Raphael B, Ollerton R. Disaster medical assistance teams: what psychosocial support is needed? Prehospital Disaster Med. 2008;23:202–7.PubMedGoogle Scholar
  47. 47.
    Peppiatt R, Byass P. A survey of the health of British missionaries. Br J Gen Pract. 1991;41:159–62.PubMedGoogle Scholar
  48. 48.
    Vivancos R, Abubakar I, Hunter PR. Foreign travel, casual sex, and sexually transmitted infections: systematic review and meta-analysis. Int J Infect Dis. 2010;14:e842–51.CrossRefPubMedGoogle Scholar
  49. 49.
    Ward BJ, Plourde P. Travel and sexually transmitted infections. J Travel Med. 2006;13:300–17.CrossRefPubMedGoogle Scholar
  50. 50.
    Gluckman SJ. Acute respiratory infections in a recently arrived traveler to your part of the world. Chest. 2008;134:163–71.CrossRefPubMedGoogle Scholar
  51. 51.
    Dahlgren AL, DeRoo L, Avril J, et al. Health risks and risk-taking behaviors among International Committee of the Red Cross (ICRC) expatriates returning from humanitarian missions. J Travel Med. 2009;16:382–90.CrossRefPubMedGoogle Scholar
  52. 52.
    Wilson ME, Wald LH, Boggild A, et al. Fever in Returned Travelers: Results from the GeoSentinel Surveillance Network. Clin Infect Dis. 2007;44:1560–8.CrossRefPubMedGoogle Scholar
  53. 53.
    Jung P, Banks RH. Tuberculosis risk in US Peace Corps Volunteers, 1996 to 2005. J Travel Med. 2008;15:87–94.CrossRefPubMedGoogle Scholar
  54. 54.
    Cobelens FG, Deutekom H, Draayer-Jansen IW, et al. Risk of infection with Mycobacterium tuberculosis in travelers to areas of high tuberculosis endemicity. Lancet. 2000;356:461–5.CrossRefPubMedGoogle Scholar
  55. 55.
    Gardner A, Cohen T, Carter EJ. Tuberculosis among participants in an academic global health medical exchange program. J Gen Intern Med. 2011;26:841–5.CrossRefPubMedGoogle Scholar
  56. 56.
    Kortepeter M, Seaworth B, Tasker S, et al. Health care workers and researchers traveling to developing-world clinical settings: disease transmission risk and mitigation. Clin Infect Dis. 2010;551:1298–305.CrossRefGoogle Scholar
  57. 57.
    Ingram P, Fisher D, Wilder-Smith A. Latent tuberculosis infection in travelers: is there a role for screening using interferon-gamma release assays? J Travel Med. 2009;16:352–6.CrossRefPubMedGoogle Scholar
  58. 58.
    • Toovey S, Moerman F, van Gompel A. Special infectious disease risks of expatriates and long-term travelers in tropical countries. Part II: infections other than malaria. J Travel Med. 2007;14:50–60. This review provides an overview of nonmalarious health issues as pertains to expatriates.PubMedGoogle Scholar
  59. 59.
    Harrop T, Aird J, Thwaites G. How to minimize risk of acquiring tuberculosis when working in a high prevalence setting: a guide for healthcare workers. BMJ. 2011;342:818–24.CrossRefGoogle Scholar
  60. 60.
    Leutscher PD, Bagley SW. Health-related challenges in United States Peace Corps Volunteers serving for two years in Madagascar. J Travel Med. 2003;10:263–7.CrossRefPubMedGoogle Scholar
  61. 61.
    Ager A, Pasha E, Yu G, Duke T, et al. Stress, mental health, and burnout in national humanitarian aid workers in Gulu, Northern Uganda. J Traumatic Stress. 2012;25:713–20.CrossRefGoogle Scholar
  62. 62.
    Brisson M, Brisson P. Compliance with antimalarial chemoprophylaxis in a combat zone. AmJTrop Med Hyg. 2012;86:587–90.CrossRefGoogle Scholar
  63. 63.
    Trivedi K, Schlett C, Tribble D, et al. The impact of post-infectious functional gastrointestinal disorders and symptoms on the health-related quality of life of US military personnel returning from deployment to the Middle East. Dig Dis Sci. 2011;56:3602–9.CrossRefPubMedGoogle Scholar
  64. 64.
    Connor P, Porter CK, Swierczewski B, Riddle MS. Diarrhoea during military deployment: current concepts and future directions. Curr Opin Infect Dis. 2012;25:546–54.CrossRefPubMedGoogle Scholar
  65. 65.
    Mohan S, Safarty S, Hamer DH. Human Immunodeficiency Virus postexposure prophylaxis for medical trainees on international rotations. J Travel Med. 2010;17:264–8.CrossRefPubMedGoogle Scholar
  66. 66.
    Kedjarune U, Leggat PA. Dental precautions for travelers. J Travel Med. 1997;4:38–40.CrossRefPubMedGoogle Scholar
  67. 67.
    Chisick MC. Dental epidemiology of military operations. Military Medicine. 1993;158:581–5.PubMedGoogle Scholar
  68. 68.
    Richardson PS. Dental morbidity in United Kingdom armed forces, Iraq 2003. Mil Med. 2005;6:536–41.Google Scholar
  69. 69.
    Galvin S, Robertson R, Hargarten S. Injuries occurring in medical students during international medical rotations: a strategy toward maximizing safety. Family Med. 2012;44:404–7.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Cassandra M. Pierre
    • 1
  • Poh-Lian Lim
    • 2
  • Davidson H. Hamer
    • 1
    • 3
    • 4
  1. 1.Section of Infectious Diseases, Department of MedicineBoston University School of MedicineBostonUSA
  2. 2.Department of Infectious DiseasesInstitute of Infectious Disease & Epidemiology, Tan Tock Seng HospitalSingaporeSingapore
  3. 3.Center for Global Health and DevelopmentBoston UniversityBostonUSA
  4. 4.Department of International HealthBoston University School of Public HealthBostonUSA

Personalised recommendations